Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06090630 · ClinicalTrials.gov registry record · Early Phase 1
MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
A Early Phase 1 study of Breast Carcinoma and Malignant Breast Neoplasm, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 83
- Enrollment target
- 1
- Study location
NCT06090630 is a Early Phase 1 study of Breast Carcinoma and Malignant Breast Neoplasm that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 83 participants, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06090630, a Early Phase 1 study of Breast Carcinoma and Malignant Breast Neoplasm, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 83 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well an imaging technique called magnetic resonance (MR) spectroscopic imaging works in identifying breast cancer in women with benign or suspicious areas in the breast. Magnetic resonance imaging (MRI) is a diagnostic tool used to investigate the location of tumors in different organs. Since radiological pictures do not have sufficient information for tumor grades, invasive procedure such as biopsy is performed on patients with breast cancers for diagnosis. Breast tissue contains water, fat, and chemicals known as metabolites. MR spectroscopic imaging may help to characterize the various breast metabolite steady state levels and identify the differences between necrosis and tumor recurrence, which is difficult using radiological procedures such as MRI.
Conditions Studied
Interventions
- PROCEDURE Magnetic Resonance Spectroscopic Imaging
- PROCEDURE Diffusion Weighted Imaging
Study Locations (1)
California
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2017-07-31 |
| Est. Completion | 2023-02-03 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06090630
The ClinicalTrials.gov registry entry for NCT06090630 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 770-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (89% lower). The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Breast Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Magnetic Resonance Spectroscopic Imaging is the first listed.
NCT06090630 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06090630 about?
NCT06090630 is a clinical study titled "MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer". This trial studies how well an imaging technique called magnetic resonance (MR) spectroscopic imaging works in identifying breast cancer in women with benign or suspicious areas in the breast. Magnetic resonance imaging (MRI) is a diagnostic tool used to investigate the location of tumors in differe...
What is the current status of trial NCT06090630?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 83 participants. The study started on 2017-07-31. Estimated completion is 2023-02-03.
What conditions does trial NCT06090630 study?
This clinical trial studies the following conditions: Breast Carcinoma, Malignant Breast Neoplasm, Benign Breast Neoplasm.
What interventions are being tested in trial NCT06090630?
The interventions under investigation include: Magnetic Resonance Spectroscopic Imaging (PROCEDURE), Diffusion Weighted Imaging (PROCEDURE).
Who is sponsoring clinical trial NCT06090630?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06090630 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
RECRUITING · Early Phase 1
-
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
RECRUITING · Early Phase 1
-
First-in-Human Positron Emission Tomography Study Using the 18F-αvβ6-Binding-Peptide
ACTIVE NOT RECRUITING · Early Phase 1
-
Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
ACTIVE NOT RECRUITING · Early Phase 1
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.